These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36878350)

  • 1. The history, use, and challenges of therapeutic somatic cell and germline gene editing.
    Ryu J; Adashi EY; Hennebold JD
    Fertil Steril; 2023 Sep; 120(3 Pt 1):528-538. PubMed ID: 36878350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enabling Precision Medicine with CRISPR-Cas Genome Editing Technology: A Translational Perspective.
    Ilahibaks NF; Hulsbos MJ; Lei Z; Vader P; Sluijter JPG
    Adv Exp Med Biol; 2023; 1396():315-339. PubMed ID: 36454475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of genome editing tools in precision medicine research.
    Li S; Yang YY; Qiu Y; Chen Y; Xu LW; Ding QR
    Yi Chuan; 2017 Mar; 39(3):177-188. PubMed ID: 28420614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy.
    Schleidgen S; Dederer HG; Sgodda S; Cravcisin S; Lüneburg L; Cantz T; Heinemann T
    BMC Med Ethics; 2020 Sep; 21(1):87. PubMed ID: 32912206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas gene editing in the human germline.
    Bekaert B; Boel A; Cosemans G; De Witte L; Menten B; Heindryckx B
    Semin Cell Dev Biol; 2022 Nov; 131():93-107. PubMed ID: 35305903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An efficient platform for generating somatic point mutations with germline transmission in the zebrafish by CRISPR/Cas9-mediated gene editing.
    Zhang Y; Zhang Z; Ge W
    J Biol Chem; 2018 Apr; 293(17):6611-6622. PubMed ID: 29500194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
    Vermersch E; Jouve C; Hulot JS
    Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and opportunities in gene editing of B cells.
    Edelstein J; Fritz M; Lai SK
    Biochem Pharmacol; 2022 Dec; 206():115285. PubMed ID: 36241097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 for the treatment of haematological diseases: a journey from bacteria to the bedside.
    Humbert O; Samuelson C; Kiem HP
    Br J Haematol; 2021 Jan; 192(1):33-49. PubMed ID: 32506752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Mediated Base Editing: Promises and Challenges for a Viable Oncotherapy Strategy.
    Huang L; Yang C; Chen Y; Deng H; Liao Z; Xiao H
    Hum Gene Ther; 2023 Aug; 34(15-16):669-681. PubMed ID: 37276175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of muscular dystrophies by CRISPR gene editing.
    Chemello F; Bassel-Duby R; Olson EN
    J Clin Invest; 2020 Jun; 130(6):2766-2776. PubMed ID: 32478678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision genome editing in the eye.
    Suh S; Choi EH; Raguram A; Liu DR; Palczewski K
    Proc Natl Acad Sci U S A; 2022 Sep; 119(39):e2210104119. PubMed ID: 36122230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Precision gene editing technologies based on CRISPR/Cas9: a review].
    Xue S; Wang S; Liu L; Zhong Q; Cheng Z; Xiao S
    Sheng Wu Gong Cheng Xue Bao; 2023 Jul; 39(7):2566-2578. PubMed ID: 37584115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-mediated genome editing: From basic research to translational medicine.
    Jacinto FV; Link W; Ferreira BI
    J Cell Mol Med; 2020 Apr; 24(7):3766-3778. PubMed ID: 32096600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene editing technology: Towards precision medicine in inherited retinal diseases.
    Ballios BG; Pierce EA; Huckfeldt RM
    Semin Ophthalmol; 2021 May; 36(4):176-184. PubMed ID: 33621144
    [No Abstract]   [Full Text] [Related]  

  • 17. In search of: Suggesting a course of action for the scientific community to research potential impacts of heritable gene editing on the maternal carrier.
    Gravelle R
    Semin Perinatol; 2018 Dec; 42(8):522-524. PubMed ID: 30482592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision genome editing in the CRISPR era.
    Salsman J; Dellaire G
    Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genome Editing with CRISPR/Cas9: First Steps Towards a new Era in Medicine?].
    Schermer B; Benzing T
    Dtsch Med Wochenschr; 2019 Feb; 144(4):276-281. PubMed ID: 30759475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering the Delivery System for CRISPR-Based Genome Editing.
    Glass Z; Lee M; Li Y; Xu Q
    Trends Biotechnol; 2018 Feb; 36(2):173-185. PubMed ID: 29305085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.